Company intelligence / Profile preview

ID Biomedical Corporation

Quebec, Quebec, Canadafda.gov ↗

Ownership: Private
Development stage: Commercial

Overview

ID Biomedical was a leading influenza vaccine manufacturer that supplied approximately 75% of the Canadian government's influenza vaccine purchases before being acquired by GSK in 2005.

Therapeutic areas: Infectious Diseases
Modalities: Vaccines
Industry: Biotech

Drug pipeline

1 asset

Influenza A (H1N1) 2009 Monovalent Vaccine

Commercial

Indications: Influenza A (H1N1) infection

Partnerships

Government of Canada (ten-year mandate from 2001 to provide influenza vaccine)

Beyond the preview

Go deeper on ID Biomedical Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ID Biomedical Corporation.

Explore the full profile